P. Conus

Discipline

Psychologie (61) Sociologie (2) Méthodes et statistiques (1) Géographie (1) Education (1) Droit (1)

Type de document

Articles (114) Recensions (8) Colloques et conférences (6) Autres (1)

Co-auteur

Date

Source

Mot-clé

Patients (89) Patients (89) Treatment (66) Human beings (65) Psychoses (55) adulte (50) adulte (50) Schizophrenia (40) risque (35) Risk (35) jeune (33) Months (33) Symptoms (29) cohorte (28) Older people (26) effet (25) âge (24) Psychiatry (24) Age (24) Age (24) Analysis (23) adolescent (23) analyse (22) maladie (21) temps (durée) (20) association (20) Time (20) Social groups (20) Impact (20) Brain (20)

Documents écrit par P. Conus (116) | parle de P. Conus (0)

A better understanding of the impact of childhood trauma on depression in early psychosis: A differential item functioning approach.
P. Golay et al.
Diagnostic d’un premier épisode psychotique : le rôle clé du médecin généraliste [Diagnostic of a first psychotic episode : role of the general practitioner]
P. Conus et al. (20 sept. 2023)
Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study.
M. Piras et al. (4 juil. 2023)
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
J. Sjaarda et al.
Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts.
B. Giangreco et al.
Interactions between mood and paranoid symptoms affect suicidality in first-episode affective psychoses.
J. Ramain et al.
The differential impact of duration of untreated psychosis on functioning and quality of life: A threshold analysis.
P. Golay et al.
Mental health service areas in Switzerland.
N. Stulz et al.
Psychiatrie : ce qui a changé en 2022 [Psychiatry: what's new in 2022]
S. Berney et al. (18 janv. 2023)
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention.
A. Ratheesh et al. (3 janv. 2023)
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
M. Piras et al. (3 janv. 2023)
Integration of a peer practitioner in a hospital unit for patients with psychotic disorders: an exploratory qualitative study.
P. Lequin et al. (2023)
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
B.I. Perry et al.
Time of exposure to social defeat stress during childhood and adolescence and redox dysregulation on long-lasting behavioral changes, a translational study.
M. Schnider et al. (26 sept. 2022)
Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.
J. Elowe et al. (15 août 2022)
Symptom dimensions stability over time in recent onset psychosis: A prospective study.
P. Golay et al.
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
N. Laaboub et al. (17 mai 2022)
Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.
M. Piras et al. (9 mai 2022)
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
G. Schoretsanitis et al.
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.
M. Cuenod et al.
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
A.F. Pardiñas et al. (1 mars 2022)
Personality disorder among youth with first episode psychotic mania: An important target for specific treatment?
M.K. Hasty et al.
Covid-19 et santé mentale : une répétition générale ?
P. Conus (2 févr. 2022)
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
I. Khadimallah et al.
Exploring the clinical relevance of a dichotomy between affective and non-affective psychosis: Results from a first-episode psychosis cohort study.
J. Ramain et al.

next